FDA Import Refusal AEK-3499306-1/11/1 — NATCO PHARMA LTD
The FDA refused shipment AEK-3499306-1/11/1 from NATCO PHARMA LTD (India) on Jun 22, 2023. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 22, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61LCY44 APIXABAN (ANTI-COAGULANT)
- Charges
- 75